Skip to main content
TELCON RF PHARMACEUTICAL. Inc. logo

TELCON RF PHARMACEUTICAL. Inc. — Investor Relations & Filings

Ticker · 200230 ISIN · KR7200230001 KO Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2023-01-10 M&A Activity
Country KR South Korea
Listing KO 200230

About TELCON RF PHARMACEUTICAL. Inc.

http://www.telcon-rf.com

TELCON RF PHARMACEUTICAL. Inc. operates across two primary business segments: radio frequency (RF) components and pharmaceuticals. The RF division specializes in the development, manufacturing, and global sale of components for wireless communication equipment. Its main products include RF coaxial connectors, cable assemblies, coaxial couplers, and distributors. The pharmaceutical and biotechnology division is engaged in the development and sale of medicinal products.

Recent filings

Filing Released Lang Actions
기타주요경영사항(게실증 치료제 아시아 판권 계약 해지)
M&A Activity Classification · 100% confidence The document is a regulatory filing from Telcon RF Pharmaceutical regarding the termination of a licensing agreement for a diverticulitis treatment. It details the counterparty, the nature of the contract, the financial value, and the reason for termination. Since this is a specific corporate announcement regarding a business contract/transaction that does not fit into M&A, dividends, or share issues, it falls under the general regulatory filing category.
2023-01-10 Korean
전환가액의조정
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from a South Korean company (Telcon RF Pharmaceutical) detailing the adjustment of conversion prices for convertible bonds due to market price fluctuations. This type of disclosure is a standard corporate action related to capital structure and financing instruments. In the provided taxonomy, 'CAP' (Capital/Financing Update) is the most accurate category for announcements regarding changes to convertible securities, conversion prices, and associated share counts.
2023-01-02 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement from Telcon RF Pharmaceutical regarding the setting of a record date for the purpose of determining shareholders eligible to vote at the 24th Annual General Meeting. It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal notice of a corporate action (setting a record date). Given the nature of the announcement as a regulatory disclosure of a procedural step for an upcoming meeting, it fits best under the general regulatory filing category.
2022-12-15 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Telcon RF Pharmaceutical, covering the period from January 1, 2022, to September 30, 2022. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-11 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including the reporting entity, special related parties, and the purpose of holding (influencing management). This document type is specifically used to notify the market of significant changes in shareholding thresholds, which corresponds to the 'Major Shareholding Notification' category.
2022-11-04 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from a Korean company (Telcon RF Pharmaceutical) detailing the adjustment of conversion prices for convertible bonds (CBs). This type of disclosure is a standard regulatory requirement in the Korean market (KRX) when conversion prices are reset due to stock price fluctuations. It falls under the category of capital structure changes and financing updates, specifically related to convertible securities.
2022-10-31 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.